Body Lateralization and Its Effects on Respiratory Drive, Ventilation, and Pulmonary Aeration in Critically Ill Patients
LATLUNG
Analysis of Respiratory Drive Activation, Ventilation, and Pulmonary Aeration Resulting From Body Lateralization in Critically Ill Patients Under Mechanical Ventilation
2 other identifiers
interventional
30
1 country
1
Brief Summary
The goal of this quasi-experimental study is to investigate how different body positions, performed through Automatic Lateralization Therapy, affect respiratory drive, ventilation, and pulmonary aeration in critically ill adult patients under mechanical ventilation. The main questions this study aims to answer are:
- Does Automatic Lateralization Therapy, modify respiratory drive, as measured by P0.1, estimated Pmus, and sEMG of the diaphragm and parasternal muscles?
- Is there an association between respiratory drive, ventilation, and pulmonary aeration measured by Electrical Impedance Tomography (EIT) in different body positions promoted by Automatic Lateralization Therapy ? Does combining Automatic Lateralization Therapy, with Flow Bias improve physiological and functional outcomes compared to Automatic Lateralization Therapy, without Flow Bias? Participants will:
- Be positioned in different lateralization strategies using Automatic Lateralization Therapy, while under mechanical ventilation;
- Have respiratory parameters and ventilation images assessed by EIT and sEMG; Participate only during their ICU stay, with no need for additional visits after discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2027
January 9, 2026
January 1, 2026
2 years
November 14, 2025
January 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Respiratory drive parameters: Surface electromyography (sEMG)
The respiratory drive parameter will be assessed using surface electromyographic (sEMG) activity of the respiratory muscles, including the diaphragm and parasternal intercostals, expressed in microvolts (µV) (Silva Junior et al., 2023). Data are given in: • µV: Microvolts Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes \| Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes for patients undergoing Bilateral Lateralization Therapy.
Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes (6 hour 10 minutes)
Respiratory drive parameter: P0.1 (airway occlusion pressure during the first 100 ms of the inspiratory effort)
The respiratory drive parameter will be assessed by P0.1(airway occlusion pressure during the first 100ms of the inspiratory effort,cmH₂O).P0.1 is the drop in airway pressure within 100 ms after the onset of inspiration and is considered a reliable, fast, and feasible bedside marker.The following values are considered: Normal: 1.5-3.5 cmH₂O; Low: \<1.0 cmH₂O(hypostimulated); High:\>4.0 cmH₂O (hyperstimulated)(CHEN et al.,2023). Data are given in: cmH₂O: centimeters of water Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes \| Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes Bilateral.
Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes(6 hour 10 minutes)
Respiratory drive parameters: Pmus (estimated inspiratory muscle pressure)
The respiratory drive will be assessed using Pmus (estimated inspiratory muscle pressure). Pmus is derived from the airway pressure drop during a brief inspiratory occlusion and reflects inspiratory effort. Reference ranges: Pmus \< 5 cmH₂O indicates over-assistance/low drive; Pmus ≤ 10 cmH₂O represents the diaphragmatic protection zone; Pmus \> 13-15 cmH₂O indicates excessive effort (Dianti, Bertoni ;Goligher, 2020). Data are given in: •cmH₂O: centimeters of water Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes \| Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes for patients undergoing Bilateral
Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes (6 hour 10 minutes)
Pulmonary ventilation: Ventilation Impedance Change (ΔZ)
ΔZ will be quantified using electrical impedance tomography (EIT). ΔZ represents the sum of impedance changes of all pixels within a predefined region of interest (ROI), corresponding to regional tidal ventilation. ROIs will include right anterior, left anterior, right posterior, and left posterior lung regions, and will also be categorized as dependent or non-dependent lung areas. Data will be expressed in arbitrary units (a.u.). Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes \| Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes for patients undergoing Bilateral Lateralization Therapy.
Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes (6 hour 10 minutes)
Pulmonary aeration: End-Expiratory Lung Impedance Change (ΔEELZ)
ΔEELZ will be assessed using electrical impedance tomography (EIT). ΔEELZ corresponds to the aggregate end-expiratory impedance (sum of pixel values) within each ROI, representing changes in end-expiratory lung volume. ROIs will include right anterior, left anterior, right posterior, and left posterior lung regions, grouped as dependent or non-dependent areas. Data will be expressed in arbitrary units (a.u.). Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes \| Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes for patients undergoing Bilateral Lateralization Therapy.
Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes (6 hour 10 minutes)
Secondary Outcomes (18)
Mechanical response associated with respiratory drive: Diaphragmatic excursion
Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes (6 hour 10 minutes)
Mechanical response related to respiratory effort and lung stress: Dynamic transpulmonary driving pressure
Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes (6 hour 10 minutes)
Driving Pressure (cmH₂O)
Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes (6 hour 10 minutes)
Respiratory System Compliance (mL/cmH₂O)
Unilateral: 140 minutes (2 hours and 20 minutes) Bilateral: 370 minutes (6 hours and 10 minutes)
Airway Resistance (cmH₂O/L/s)
Unilateral: 140 minutes (2 hours and 20 minutes) Bilateral: 370 minutes (6 hours and 10 minutes)
- +13 more secondary outcomes
Other Outcomes (1)
Clinical Severity - SAPS 3 (Baseline)
Baseline (pre-intervention).
Study Arms (2)
Supine Positioning
ACTIVE COMPARATORParticipants will remain in supine position with 30° head elevation. No lateralization therapy is applied.
Automatic lateralization therapy
ACTIVE COMPARATORParticipants will undergo continuous lateral positioning on an automated bed, with automatic angle and time adjustments. The second sequence will be combined with the Flow Bias intervention.
Interventions
During this phase of analysis and intervention related to lateral positioning, patients will be maintained on a Multicare bed (LINET) and subjected to personalized lateral positioning based on the morphofunctional pattern detected by electrical impedance tomography. This positioning will be performed using automatic lateralization therapy, programmed for unilateral or bilateral application, continuously alternating between angles of 0°, 15°, and 30°, maintained for 20 minutes at each position. The procedure will be conducted in two sequences, with the second sequence combined with the Flow Bias intervention. At each angle, data will be collected on hemodynamic monitoring, respiratory drive, respiratory mechanics, regional distribution of ventilation and aeration, and gas exchange.
During this analysis phase, patients will be positioned on a Multicare bed (LINET) in the dorsal decubitus position with the head of the bed elevated to 30°. Data will be collected on hemodynamic monitoring, respiratory drive, respiratory mechanics, degree of lung involvement, regional distribution of ventilation and aeration, and gas exchange.
Eligibility Criteria
You may qualify if:
- Patients of both sexes will be included;
- Aged ≥ 18 years;
- BMI 18-35 kg/m²;
- Under invasive mechanical ventilation via orotracheal tube for ≥ 24 hours and expected to remain on mechanical ventilatory support for at least 48 hours;
- Sedated (Richmond Agitation-Sedation Scale \[RASS\] -1 to -4);
- Well adapted to protective ventilation strategies in VCV or PSV modes;
- Presenting neural respiratory drive evidenced by a drop in Delta Pocc and/or the presence of assisted cycles;
- Hemodynamically stable (mean arterial pressure between 60-120 mmHg, systolic arterial pressure between 90-180 mmHg, diastolic arterial pressure between 60-100 mmHg, and heart rate between 50-150 bpm) with or without vasoactive drugs at the time of data collection (\> 0.1 to 0.3 mcg/kg/min);
- Respiratory stability, no use of accessory muscles and target SpO₂ achieved;
- No indication for nebulization or heated humidification at the time of collection;
- Positive tolerance test for lateral decubitus positioning;
- Chest circumference of 78-87.9 cm (XS), 88-99.9 cm (S), or 100-111.9 cm (M).
You may not qualify if:
- Patients presenting medical restrictions to body repositioning, or to the use of EIT or sEMG;
- Those in therapeutic failure;
- Individuals with spinal cord injury, brain injury, or stroke with a history of functional loss and respiratory impairment prior to hospitalization;
- Neurological diseases affecting respiratory myoelectric conduction;
- History of postural deformities, diaphragmatic abnormalities, or colostomy bag;
- Unstable fracture (lower or upper limbs in proximal regions or thorax);
- Pleural effusion requiring drainage;
- Presence of drains in the thoracic and/or abdominal regions;
- Unstable intracranial pressure;
- Pregnant patients;
- Immediate postoperative period of orthopedic surgeries;
- Use of mucolytics;
- Open ventriculostomy for drainage;
- Uncontrolled agitation;
- Pacemaker or implantable cardioverter-defibrillator;
- +11 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Geral Otávio de Freitas - Secretaria de Saúde de Pernambuco
Recife, Pernamu, 50670-901, Brazil
Related Publications (25)
Salluh JI, Soares M. ICU severity of illness scores: APACHE, SAPS and MPM. Curr Opin Crit Care. 2014 Oct;20(5):557-65. doi: 10.1097/MCC.0000000000000135.
PMID: 25137401BACKGROUNDDianti J, Bertoni M, Goligher EC. Monitoring patient-ventilator interaction by an end-expiratory occlusion maneuver. Intensive Care Med. 2020 Dec;46(12):2338-2341. doi: 10.1007/s00134-020-06167-3. Epub 2020 Jul 4. No abstract available.
PMID: 32623476BACKGROUNDChen H, Liang M, He Y, Teboul JL, Sun Q, Xie J, Yang Y, Qiu H, Liu L. Inspiratory effort impacts the accuracy of pulse pressure variations for fluid responsiveness prediction in mechanically ventilated patients with spontaneous breathing activity: a prospective cohort study. Ann Intensive Care. 2023 Aug 17;13(1):72. doi: 10.1186/s13613-023-01167-0.
PMID: 37592166BACKGROUNDSilva Junior EFFD, Campos SL, Leite WS, Melo PVS, Lins RAC, Araujo MDGR, Guerino MR. Surface electromyography signal processing and evaluation on respiratory muscles of critically ill patients: A systematic review. PLoS One. 2023 Apr 27;18(4):e0284911. doi: 10.1371/journal.pone.0284911. eCollection 2023.
PMID: 37104255BACKGROUNDCosta LSP, Reinaux CMA, Junior EFFS, Leite WS, Brandao DC, de Andrade AD, Roldan R, Morais CCA, Campos SL. Physiology of body lateralization on regional lung ventilation and lung volumes in healthy subjects: Within-subjects design. PLoS One. 2025 Oct 30;20(10):e0335622. doi: 10.1371/journal.pone.0335622. eCollection 2025.
PMID: 41166369BACKGROUNDZack MB. Pectoriloquy, a retrospective analysis. Chest. 2009 Jan;135(1):8-9. doi: 10.1378/chest.08-2261. No abstract available.
PMID: 19136401BACKGROUNDVedrenne-Cloquet M, Ito Y, Hotz J, Klein MJ, Herrera M, Chang D, Bhalla AK, Newth CJL, Khemani RG. Phenotypes based on respiratory drive and effort to identify the risk factors when P0.1 fails to estimate ∆PES in ventilated children. Crit Care. 2024 Oct 4;28(1):325. doi: 10.1186/s13054-024-05103-x.
PMID: 39367452BACKGROUNDUmbrello M, Formenti P, Longhi D, Galimberti A, Piva I, Pezzi A, Mistraletti G, Marini JJ, Iapichino G. Diaphragm ultrasound as indicator of respiratory effort in critically ill patients undergoing assisted mechanical ventilation: a pilot clinical study. Crit Care. 2015 Apr 13;19(1):161. doi: 10.1186/s13054-015-0894-9.
PMID: 25886857BACKGROUNDSuttapanit K, Wongkrasunt S, Savatmongkorngul S, Supatanakij P. Ultrasonographic evaluation of the diaphragm in critically ill patients to predict invasive mechanical ventilation. J Intensive Care. 2023 Sep 19;11(1):40. doi: 10.1186/s40560-023-00690-3.
PMID: 37726832BACKGROUNDSchifino G, Vega ML, Pisani L, Prediletto I, Catalanotti V, Comellini V, Bassi I, Zompatori M, Ranieri MV, Nava S. Effects of non-invasive respiratory supports on inspiratory effort in moderate-severe COVID-19 patients. A randomized physiological study. Eur J Intern Med. 2022 Jun;100:110-118. doi: 10.1016/j.ejim.2022.04.012. Epub 2022 Apr 22.
PMID: 35483993BACKGROUNDROSA, Jéssica dos Santos Pereira et al. Impacts in the Respiratory Mechanics of the Ventilator Hyperinsuflation in the Flow Bias Concept: a Narrative Review. Journal of Health Sciences, v. 21, n. 3, p. 250-254, 2019.
BACKGROUNDRoesthuis LH, van der Hoeven JG, van Hees HWH, Schellekens WM, Doorduin J, Heunks LMA. Recruitment pattern of the diaphragm and extradiaphragmatic inspiratory muscles in response to different levels of pressure support. Ann Intensive Care. 2020 May 29;10(1):67. doi: 10.1186/s13613-020-00684-6.
PMID: 32472272BACKGROUNDDos Santos Rocha A, Diaper J, Balogh AL, Marti C, Grosgurin O, Habre W, Petak F, Sudy R. Effect of body position on the redistribution of regional lung aeration during invasive and non-invasive ventilation of COVID-19 patients. Sci Rep. 2022 Jun 30;12(1):11085. doi: 10.1038/s41598-022-15122-9.
PMID: 35773299BACKGROUNDPearce AK, McGuire WC, Elliott AR, Goligher EC, Prisk GK, Butler JP, Malhotra A. Impact of Supine Versus Semirecumbent Body Posture on the Distribution of Ventilation in Acute Respiratory Distress Syndrome. Crit Care Explor. 2023 Dec 1;5(12):e1014. doi: 10.1097/CCE.0000000000001014. eCollection 2023 Dec.
PMID: 38053751BACKGROUNDKubota S, Hashimoto H, Yoshikawa Y, Hiwatashi K, Ono T, Mochizuki M, Naraba H, Nakano H, Takahashi Y, Sonoo T, Nakamura K. Effects of mechanical insufflation-exsufflation on ventilator-free days in intensive care unit subjects with sputum retention; a randomized clinical trial. PLoS One. 2024 May 2;19(5):e0302239. doi: 10.1371/journal.pone.0302239. eCollection 2024.
PMID: 38696429BACKGROUNDHuerta MDR, Giralt JAS, Diez-Fernandez A, Alonso MJR, Montes N, Suarez-Sipmann F. Effects of routine postural repositioning on the distribution of lung ventilation and perfusion in mechanically ventilated patients. Intensive Crit Care Nurs. 2025 Apr;87:103952. doi: 10.1016/j.iccn.2025.103952. Epub 2025 Jan 25.
PMID: 39864264BACKGROUNDGong S, Lian H, Ding X, Wang X; Chinese Critical Ultrasound Study Group (CCUSG). High Respiratory and Cardiac Drive Exacerbate Secondary Lung Injury in Patients With Critical Illness. J Intensive Care Med. 2025 Mar;40(3):231-238. doi: 10.1177/08850666231222220. Epub 2024 Jan 3.
PMID: 38173252BACKGROUNDFranchineau G, Jonkman AH, Piquilloud L, Yoshida T, Costa E, Roze H, Camporota L, Piraino T, Spinelli E, Combes A, Alcala GC, Amato M, Mauri T, Frerichs I, Brochard LJ, Schmidt M. Electrical Impedance Tomography to Monitor Hypoxemic Respiratory Failure. Am J Respir Crit Care Med. 2024 Mar 15;209(6):670-682. doi: 10.1164/rccm.202306-1118CI.
PMID: 38127779BACKGROUNDCherniack NS, Lederer DH, Altose MD, Kelsen SG. Occlusion pressure as a technique in evaluating respiratory control. Chest. 1976 Jul;70(1 Suppl):137-41. doi: 10.1378/chest.70.1_supplement.137. No abstract available.
PMID: 939129BACKGROUNDCaetano DS, Morais CC, Leite WS, Lins RAC, Medeiros KJ, Cornejo RA, de Andrade AD, Campos SL, Brandao DC. Electrical Impedance Tomographic Mapping of Hypoventilated Lung Areas in Intubated Patients With COVID-19. Respir Care. 2023 Jun;68(6):773-776. doi: 10.4187/respcare.10261. Epub 2023 Apr 25. No abstract available.
PMID: 37185111BACKGROUNDBrito ALA, Ferreira ACA, Costa LSP, Silva Junior EFF, Campos SL. Effect of Continuous Lateral Rotation Therapy on Clinical Outcomes in Mechanically Ventilated Critically Ill Adults. Respir Care. 2024 Nov 18;69(12):1592-1606. doi: 10.4187/respcare.11781.
PMID: 38744476BACKGROUNDBonczynski GS, Novo JS, Dias AS, Martins LFG, Naue WDS, Volpe MS, Junior LAF. Ventilator hyperinflation associated with flow bias optimization in the bronchial hygiene of mechanically ventilated patients. Heart Lung. 2024 Mar-Apr;64:31-35. doi: 10.1016/j.hrtlng.2023.10.011. Epub 2023 Nov 21.
PMID: 37988854BACKGROUNDBertoni M, Telias I, Urner M, Long M, Del Sorbo L, Fan E, Sinderby C, Beck J, Liu L, Qiu H, Wong J, Slutsky AS, Ferguson ND, Brochard LJ, Goligher EC. A novel non-invasive method to detect excessively high respiratory effort and dynamic transpulmonary driving pressure during mechanical ventilation. Crit Care. 2019 Nov 6;23(1):346. doi: 10.1186/s13054-019-2617-0.
PMID: 31694692BACKGROUNDAmerican Association for Respiratory Care. AARC Clinical Practice Guidelines. Endotracheal suctioning of mechanically ventilated patients with artificial airways 2010. Respir Care. 2010 Jun;55(6):758-64.
PMID: 20507660BACKGROUNDAlcala GC, Ekkapat G, Medeiros KJ, Morais CCA, Xin Y, Giammatteo V, Bruno G, Nova A, Wanderley H, Buhl T, Victor M, Gaulton TG, La Vita CJ, Amato MBP, Ceradda M, Berra L, Ribeiro De Santis Santiago R. Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit. J Vis Exp. 2024 Sep 6;(211). doi: 10.3791/66756.
PMID: 39311582BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emanuel Fernandes Ferreira da Silva Júnior, MSc
Federal University of Pernambuco (UFPE) - Health-Applied Biology Graduate Program, Federal University of Pernambuco, Recife, Brazil
- STUDY DIRECTOR
Shirley Lima Campos Lima Campos, PhD
Universidade Federal de Pernambuco
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Apart from the participants and the researchers responsible for data analysis, no other role is blinded in the study. The researchers responsible for carrying out the interventions and conducting the study are not blinded to the intervention conditions. Blinding is applied only to: * Participants: sedated and, therefore, unaware of the intervention received. * Researchers responsible for data analysis: blinded to the intervention conditions during the evaluation of physiological and ventilatory parameters.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Researcher
Study Record Dates
First Submitted
November 14, 2025
First Posted
January 7, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
December 30, 2027
Study Completion (Estimated)
December 30, 2027
Last Updated
January 9, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Through study completion
- Access Criteria
- Individual participant data (IPD) access will be granted by the PI after request review for approval via email. It will be shared with researchers and general public of interest on the subject for descriptive analyses related to our sample. A committee of researchers will be in charge of discussing the request before approving the access.
Participant characteristics Medical history Clinical measurements Functional results Images (USG) Adverse events